Dr. Christopher Boerner

CHRISTOPHER BOERNER is currently the president and head of the U.S. commercial business at Bristol-Myers Squibb. He joined BMS in February 2015. Prior to this role, Boerner served as the executive vice president of commercial for Seattle Genetics, Inc., where he was responsible for leading all commercial activities for the company. Previously, he was its senior vice president of commercial and its vice president of marketing. Before joining Seattle Genetics, Boerner was with Dendreon Corporation, where he led the marketing team. From 2002 to 2010, he was with Genentech, a member of the Roche Group, where he served in a variety of commercial roles, including director of marketing on Avastin, director of Avastin franchise strategy and associate director of oncology market development. Prior to Genentech, he was with McKinsey & Company, a global strategic management consulting firm, where he served global pharmaceutical and biotechnology clients. Dr. Boerner earned a Ph.D. and M.A. in business administration from the Haas School of Business at the University of California, Berkeley, and also an A.B. in economics and history from Washington University in St. Louis. @bmsnews